HLS THERAPEUTICS INC (HLTRF:OTCMKTS)
$3.38 0 (0%)
Analysed HLS THERAPEUTICS INC (HLTRF:OTCMKTS) News Sources
HLS Therapeutics to Present at the 2026 Bloom Burton & Co. Healthcare Investor Conference
14-04-2026
yahoo.com
HLS Therapeutics Q4 Earnings Call Highlights
13-03-2026
marketbeat.com
HLS Therapeutics Inc (HLTRF) Q4 2025 Earnings Call Highlights: Strong EBITDA Growth and ...
12-03-2026
yahoo.com
HLS Therapeutics Announces Fiscal 2025 Financial Results
12-03-2026
yahoo.com
/C O R R E C T I O N -- HLS Therapeutics Inc./
05-03-2026
yahoo.com
HLS Therapeutics to Host Fiscal 2025 Financial Results Conference Call
26-02-2026
yahoo.com
The past five years for HLS Therapeutics (TSE:HLS) investors has not been profitable
12-12-2025
yahoo.com
How Recent Changes Are Shaping the Story for HLS Therapeutics in Analysts’ Eyes
21-11-2025
yahoo.com
HLS Therapeutics Announces Health Canada Approval of NILEMDO® for the Reduction of LDL-Cholesterol in Canadians at Risk of Cardiovascular Disease
18-11-2025
yahoo.com
Esperion Partner HLS Therapeutics Announces Approval of NILEMDO® for the Reduction of LDL-Cholesterol in Canadians at Risk of Cardiovascular Disease
18-11-2025
yahoo.com
What is the current price of HLS THERAPEUTICS INC (HLTRF:OTCMKTS)?
The current price of HLS THERAPEUTICS INC (HLTRF:OTCMKTS) is $3.38.
HLS THERAPEUTICS INC (HLTRF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of HLS THERAPEUTICS INC (HLTRF:OTCMKTS) since the previous trading day is $0.
HLS THERAPEUTICS INC (HLTRF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of HLS THERAPEUTICS INC (HLTRF:OTCMKTS) since the previous trading day is 0%.
What is the most recent average sentiment score for HLS THERAPEUTICS INC (HLTRF:OTCMKTS)?
The most recent average sentiment score for HLS THERAPEUTICS INC (HLTRF:OTCMKTS) is 78 out of 100.
What is the most recent average sentiment for HLS THERAPEUTICS INC (HLTRF:OTCMKTS)?
The most recent sentiment for HLS THERAPEUTICS INC (HLTRF:OTCMKTS) is .
SEC-8K** Filing Available For HLS THERAPEUTICS INC (HLTRF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.